Wade MR: Difference between revisions
From Bioblast
No edit summary |
Beno Marija (talk | contribs) |
||
| (7 intermediate revisions by 4 users not shown) | |||
| Line 2: | Line 2: | ||
|lastname=Wade | |lastname=Wade | ||
|firstname=Mark | |firstname=Mark | ||
|institution=Eli Lilly and Co. | |||
|institution= | |||
|address= | Lilly Corporate Center/DC0545 | ||
|area code= | |address=893 S Deleware | ||
|area code=46285 | |||
|city=Indianapolis | |city=Indianapolis | ||
|state=Indiana (IN) | |||
|country=USA | |country=USA | ||
}} | }} | ||
{{Labelingperson | {{Labelingperson | ||
|field of research= | |field of research=Pharmacological | ||
}} | }} | ||
== Participated at == | |||
::::* [[MiPNet20.05 IOC104 Greenville |IOC104 Greenville NC US]] | |||
::::* [[MiPNet19.06 IOC91 Philadelphia US |IOC91 Philadelphia US]] | |||
Latest revision as of 11:09, 14 February 2018
| Name | Wade Mark, |
|---|---|
| Institution | Eli Lilly and Co.
Lilly Corporate Center/DC0545 |
| Address | 893 S Deleware, 46285 |
| City | Indianapolis |
| State/Province | Indiana (IN) |
| Country | USA |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | US IN Indianapolis Brozinick JT |
Labels:
Field of research: Pharmacological
Publications
Add references to your publications
